IN BRIEF: OptiBiotix Health CEO and division chief buy shares

Wed, 21st Apr 2021 14:44

OptiBiotix Health PLC - York, England-based developer of compounds to treat obesity, high cholesterol, diabetes and skincare - Chief Executive Officer Stephen O'Hara buys 47,857 shares at 53.0 pence, and Rene Kamminga, CEO of OptiBiotix Ltd, buys 35,000 shares at 52.4p, together worth GBP43,704, on Tuesday. O'Hara now has 10.2 million shares, a 11.6% stake, while the purchase is Kamminga's only holding.

Current stock price: 52.40 pence

Year-to-date change: down 9.7%

By Tom Waite; thomaslwaite@alliancenews.com

Related Shares

More News

30 Apr 2024 16:55

OptiBiotix Health inks manufacturing deal with KAG Industries

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its its Indian subsidiary, OptiBiotix Health India (OHI), has ent...

30 Apr 2024 15:56

EARNINGS AND TRADING: Card Factory profit climbs; Pebble "consistent"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

25 Mar 2024 17:08

OptiBiotix Health raises GBP1.4 million to invest in "driving sales"

(Alliance News) - OptiBiotix Health PLC on Monday said it has raised GBP1.4 million through a placing and subscription of shares.

13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

13 Mar 2024 14:28

OptiBiotix signs partnership with India's Dr Morepen

(Sharecast News) - Life science company OptiBiotix Health announced the signing of a partnership agreement with Dr Morepen on Wednesday, for the distr...